Nation Johnson & Johnson to pay $572 million for role in opioid crisis; company says ruling ‘flawed’ August 26, 2019John Bacon, USA TODAYComments Off on Johnson & Johnson to pay $572 million for role in opioid crisis; company says ruling ‘flawed’ The state previously settled with OxyContin-maker Purdue Pharma and Israel's Teva Pharmaceutical for a total of more than $350 million.